Immune response after rabies vaccine in a kidney transplant recipient

Transplant Infectious Disease

Volumn 13, Issue 5, 2011, Pages 492-495

  Rodriguez Romo R ^a   Morales Buenrostro, L E ^a   Lecuona, L ^b   Escalante Santillan N ^c   Velasco Villa, A ^d   Kuzmin, I ^d   Rupprecht, C E ^d   De Leo, C ^a   Ramirez J ^a   Alberu J ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

^c Jurisdiccion Sanitaria Tizayuca City   (Mexico)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Adequate immune response; Kidney transplant recipient; Rabies virus

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RABIES; VACCINATION;

ADULT; ANTIBODIES, VIRAL; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULINS; KIDNEY TRANSPLANTATION; MALE; RABIES; RABIES VACCINES;

EID: 80053606523     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00665.x     Document Type: Article

References (16)

1. Jackson AC. Rabies. Neurol Clin 2008; 26: 717-726.
2. Bahmanyar M, Fayaz A, Nour-Salehi S, Mohammadi M, Koprowski H. Successful protection of humans exposed to rabies infection: post-exposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA 1976; 236: 2751-2754.
3. World Health Organization. WHO expert consultation on rabies: first report. Geneva: WHO, 2005.
4. CENAVECE, Ministry of Health, Mexico. Available at Accessed March 2, 2011.
5. Lucas CH, Pino FV, Baer G, et al. Rabies control in Mexico. Dev Biol (Basel) 2008; 131: 167-175.
6. CENAVECE, Ministry of Health, Mexico. Guía para la atención médica y antirrábica de la persona expuesta al virus de la rabia. Available at Accessed March 2, 2011.
7. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352: 1103-1111.
8. Johnson N, Brookes SM, Fooks AR, Ross RS. Review of human rabies cases in the UK and in Germany. Vet Rec 2005; 157: 715.
9. Jackson AC. Human disease. In: Jackson AC, Wunner WH, eds. Rabies (2nd edn). Amsterdam: Elsevier Academic Press, 2007: 309-340.
10. Cramer CH II, Shieck V, Thomas SE, Kershaw DB, Magee JC, Lopez MJ. Immune response to rabies vaccination in pediatric transplant patients. Pediatr Transplant 2008; 12: 874-877.
11. Centers for Disease Control and Prevention. Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57: 1-28.
12. Alberú J, Villasís A. Virus, inmunosupresión y el receptor de trasplante renal. Rev Invest Clin 2005; 57: 582-595.
13. Modificación a la Norma Oficial Mexicana NOM-011-SSA2-1993, para la prevención y control de la rabia, publicada el 25 de Enero de 1995
14. Smith JS, Yager PA, Baer GM. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibodies In: Kaplan MM, Koprowski H, Meslin FX, eds. Laboratory Techniques in Rabies. 4th edn. Geneva: WHO, 1996: 181-192.
15. WHO. Weekly epidemiological record, August 6, 2010, 85th year. No. 32, 2010; 85, 309-320. Available at Accessed March 2, 2011.
16. WHO. Rabies immunization. Available at Accessed March 2, 2011.